Life Sciences Snapshot - A Quarterly Report on Financing Trends
Gregg Griner is a partner in Orrick’s Technology Companies Group. His practice encompasses all areas of general corporate and securities law, with extensive experience in corporate finance, including public offerings and private placements of equity and debt, mergers and acquisitions, and venture capital fund formation.
Gregg represents companies in all stages of their life cycles, from start-ups to public companies, and in a variety of industries including, software, hardware, information services, financial services, financial technology, consumer goods, fashion, media, energy, medical devices and pharmaceuticals. He advises these companies in many aspects of their businesses including financings, corporate governance, employment matters, acquisitions, divestitures, licensing and distribution arrangements, and joint ventures and strategic partnerships.
Gregg also represents venture capital firms in their formation, fundraising efforts and maintenance, as well as in their investments in early and later stage operating companies and in complex leveraged transactions and restructurings. Gregg has worked with a number of leading technology and life science companies in connection with their initial and follow-on public offerings, M&A activities and leading investment banks in their underwriting of public equity and debt offerings.